Compare
TFA Therapeutics, Inc. vs Adia Med, Inc. vs Target Group Inc. vs Healthy Extracts Inc.
| Latest fiscal year | TFA Therapeutics, Inc. RAJAF | Adia Med, Inc. ADIA | Target Group Inc. CBDY | Healthy Extracts Inc. HYEX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.25M | $700.5K | $3.88M | $4.51M |
| Revenue growth (YoY) | -0.6% | n/m | -41.1% | +44.9% |
| Gross margin | 61.1% | 27.4% | 53.3% | 53.7% |
| Operating margin | -11.3% | -52.3% | n/a | n/a |
| Net margin | -12.4% | -56.5% | -35.0% | -19.5% |
| Net income | -$154.8K | -$395.5K | -$1.36M | -$881.1K |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | n/a |
| Operating cash flow | -$35.8K | -$179.2K | -$842.4K | $165.5K |
| Free cash flow | n/a | -$192.4K | n/a | n/a |
| Cash & equivalents | $3.2K | $79.4K | n/a | n/a |
| Total assets | $4.66M | $594.8K | $6.18M | $27.82M |
| Total liabilities | $5.19M | $852.5K | $14.24M | $3.80M |
| Shareholders' equity | -$534.6K | -$257.7K | -$8.06M | $24.03M |
| Return on year-end equity | n/a | n/a | n/a | -3.7% |
| Shares outstanding | 111.12M | n/a | 617.03M | 16.87M |
Revenue, most recent five fiscal years
| Fiscal year | TFA Therapeutics, Inc. | Adia Med, Inc. | Target Group Inc. | Healthy Extracts Inc. |
|---|---|---|---|---|
| Latest | $1.25M Ended 2025-12-31 | $700.5K Ended 2025-12-31 | $3.88M Ended 2025-12-31 | $4.51M Ended 2025-12-31 |
| 1 year earlier | $1.25M Ended 2024-12-31 | $6.4K Ended 2024-12-31 | $6.59M Ended 2024-12-31 | $3.11M Ended 2024-12-31 |
| 2 years earlier | $882.5K Ended 2023-12-31 | n/a | $3.72M Ended 2023-12-31 | $2.49M Ended 2023-12-31 |
| 3 years earlier | $53.3K Ended 2022-12-31 | n/a | $0 Ended 2022-12-31 | $2.25M Ended 2022-12-31 |
| 4 years earlier | $879.3K Ended 2021-12-31 | n/a | $0 Ended 2021-12-31 | $1.68M Ended 2021-12-31 |